CLNV Clean Vision Corp
Industrial Organic Chemicals · OTC · SEC CIK 1391426 · Fiscal year ends 12/31
Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY40.2%
TTM net income YoY-21.0%
TTM EPS YoY33.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin92.2%
Operating margin-3,321.9%
Net margin-5,547.7%
FCF margin—
EBITDA margin-3,226.7%
Returns
ROE—
ROA-88.5%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets174.2%
Debt / equity—
Current ratio0.30x
Interest coverage-1.71x
Cash quality & payout
Operating cash flow / net income0.65x
Accruals ratio-30.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 | 2024Q22024-06-30 | 2024Q12024-03-31 | 2023Q4*2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $62,064 | $52,612 | $10,525 | $123,094 | $34,799 | $23,455 | $49,692 | $69,209 |
| Cost of revenue | $9,210 | $8,147 | $1,944 | $167 | $2,149 | $12,100 | $2,985 | — |
| Gross profit | $52,854 | $44,465 | $8,581 | $122,927 | $32,650 | $11,355 | $52,677 | -$3,143 |
| R&D expense | $8,800 | $30,443 | $2,420 | $112,743 | $172,523 | $20,858 | $28,515 | — |
| SG&A expense | $597,647 | $663,981 | $212,721 | $389,469 | $127,125 | $333,924 | $338,955 | -$96,520 |
| Operating income | -$1.22M | -$1.93M | -$1.03M | -$4.07M | -$925,203 | -$873,813 | -$1.32M | -$5.12M |
| Interest expense | $893,445 | $703,145 | $632,397 | $2.58M | $604,056 | $883,764 | $1.48M | $1.50M |
| Pretax income | -$1.87M | -$473,305 | -$3.29M | -$8.48M | -$1.60M | -$1.91M | -$2.22M | -$5.82M |
| Net income | -$1.83M | -$417,359 | -$3.23M | -$8.30M | -$1.55M | -$1.82M | -$2.17M | -$5.84M |
| EBITDA | -$1.17M | -$1.88M | -$977,626 | -$3.99M | -$886,965 | -$835,947 | -$1.26M | -$5.02M |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 1.06B | 1.01B | 898.02M | — | 746.30M | 70.13M | 690.75M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.98M | $3.51M | $1.80M | $1.30M | $4,180 | $64,454 | $266,227 | $339,921 |
| Receivables | $28,415 | $34,083 | $9,238 | $37,624 | $8,152 | $7,930 | $62,735 | $70,745 |
| Inventory | $8,385 | — | — | — | — | — | — | — |
| Current assets | $6.31M | $7.74M | $7.81M | $3.42M | $505,917 | $598,258 | $1.05M | $852,547 |
| PP&E, net | $7.95M | $7.33M | $5.03M | $4.79M | $4.93M | $4.94M | $4.97M | $4.88M |
| Goodwill | $4.85M | $4.85M | $4.85M | $4.85M | $4.85M | $4.85M | $4.85M | $4.85M |
| Total assets | $20.85M | $21.69M | $17.70M | $13.07M | $10.29M | $10.39M | $10.87M | $10.59M |
| Current liabilities | $21.24M | $21.04M | $21.10M | $18.45M | $14.19M | $13.68M | $12.63M | $11.28M |
| Long-term debt | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M |
| Total debt | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M | $1.75M |
| Total liabilities | $36.32M | $36.02M | $32.59M | $24.97M | $15.94M | $15.43M | $14.38M | $13.03M |
| Shareholders' equity | -$15.75M | -$14.33M | -$14.89M | -$11.90M | -$5.65M | -$5.05M | -$5.28M | -$4.24M |
| Net debt | -$229,685 | -$1.76M | -$54,821 | $447,568 | $1.75M | $1.69M | $1.48M | $1.41M |
| Shares outstanding | 1.09B | 1.04B | — | 807.61M | 798.51M | 715.66M | 695.70M | 682.46M |
| Cash flow statement | ||||||||
| Operating cash flow | -$9.60M | $6.85M | -$2.89M | -$3.36M | -$127,887 | -$407,179 | -$988,729 | -$1.29M |
| Investing cash flow | -$669,346 | -$2.35M | -$284,159 | $45,601 | -$30,844 | -$5,439 | -$142,195 | -$75,069 |
| Financing cash flow | $1.00M | $5.00M | $3.70M | $4.60M | $84,928 | $213,236 | $1.06M | $348,412 |
| Depreciation & amortization | $50,067 | $50,014 | $48,259 | $88,133 | $38,238 | $37,866 | $57,581 | $100,161 |
Free plan shows the latest 8 periods; Pro shows all 20 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.